Private Capital Group’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$46K Sell
310
-30
-9% -$4.34K 0.03% 519
2022
Q1
$56K Sell
340
-106
-24% -$17.5K 0.01% 603
2021
Q4
$97K Buy
446
+9
+2% +$1.89K 0.02% 436
2021
Q3
$83K Hold
437
0.02% 488
2021
Q2
$77K Sell
437
-2
-0.5% -$345 0.02% 507
2021
Q1
$72K Sell
439
-463
-51% -$70.8K 0.02% 497
2020
Q4
$126K Buy
902
+68
+8% +$8.57K 0.02% 431
2020
Q3
$93K Sell
834
-94
-10% -$10.9K 0.02% 469
2020
Q2
$86K Buy
928
+70
+8% +$5.96K 0.02% 491
2020
Q1
$63K Buy
858
+531
+162% +$46.1K 0.02% 553
2019
Q4
$27K Buy
327
+27
+9% +$2.09K 0.01% 988
2019
Q3
$25K Buy
+300
New +$22.7K ﹤0.01% 1097

Other funds holding MEDP

Private Capital Group's MEDP Position: Q2 2022 in Review

Private Capital Group reduced its Medpace (MEDP) stake by 8.8% in Q2 2022, selling an estimated $4.34K and leaving 310 shares worth $46K. The position accounts for 0.03% of the portfolio, ranked #519.

Private Capital Group first reported a position in MEDP in Q3 2019 and has held it in 12 quarters since. The position peaked at $126K in Q4 2020. 338 funds tracked by Wall St. Rank hold MEDP as of Q2 2022.

  • Private Capital Group held 310 shares of Medpace worth $46K as of Q2 2022.
  • Private Capital Group sold 30 Medpace shares in Q2 2022, an estimated $4.34K.
  • Medpace made up 0.03% of Private Capital Group's portfolio in Q2 2022, its #519 holding.
  • Private Capital Group first reported a position in Medpace in Q3 2019 and has held it in 12 quarters since.
  • Private Capital Group's Medpace position peaked at $126K in Q4 2020.
  • 338 funds tracked by Wall St. Rank held Medpace as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.